LB
48
2
JPM
59
4
MCK
77
2
DVN
31
4
NRG
52
2
CNP
67
4
XEL
62
5
L
49
-5
SEE
29
4
CSCO
58
2
NOV
35
3
NKE
21
6
CINF
40
2
WMT
67
5
RHI
18
-2
NTRS
45
15
GPC
50
6
PEP
38
5
NEM
56
-3
PBI
43
11
LB
48
2
JPM
59
4
MCK
77
2
DVN
31
4
NRG
52
2
CNP
67
4
XEL
62
5
L
49
-5
SEE
29
4
CSCO
58
2
NOV
35
3
NKE
21
6
CINF
40
2
WMT
67
5
RHI
18
-2
NTRS
45
15
GPC
50
6
PEP
38
5
NEM
56
-3
PBI
43
11
Financhill
Back

Blueprint Medicines Stock Price Chart

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
31

BPMC
Blueprint Medicines

Last Price:
$84.71
Seasonality Move:
8.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Market's down 10% YTD Buffet's Berkshire up 13%

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Blueprint Medicines Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 81.65 Buy
20-day SMA: 85.64 Sell
50-day SMA: 91.11 Sell
200-day SMA: 95.51 Sell
8-day EMA: 82.78 Buy
20-day EMA: 84.9 Sell
50-day EMA: 89.49 Sell
200-day EMA: 92.6 Sell

Blueprint Medicines Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.69 Sell
Relative Strength Index (14 RSI): 47.15 Sell
Chaikin Money Flow: 540415 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (81.98 - 91.06) Sell
Bollinger Bands (100): (85.57 - 103.69) Sell

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Blueprint Medicines Stock

Is Blueprint Medicines Stock a Buy?

BPMC Technical Analysis vs Fundamental Analysis

Sell
31
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy or a Sell?

Blueprint Medicines Stock Info

Market Cap:
5.4B
Price in USD:
84.69
Share Volume:
634.4K

Blueprint Medicines 52-Week Range

52-Week High:
121.90
52-Week Low:
73.04
Sell
31
Blueprint Medicines (BPMC) is a Sell

Blueprint Medicines Share Price Forecast

Is Blueprint Medicines Stock a Buy?

  • Blueprint Medicines share price is 84.69 while BPMC 8-day exponential moving average is 82.78, which is a Buy signal.
  • The stock price of BPMC is 84.69 while Blueprint Medicines 20-day EMA is 84.90, which makes it a Sell.
  • Blueprint Medicines 50-day exponential moving average is 89.49 while BPMC share price is 84.69, making it a Sell technically.
  • BPMC stock price is 84.69 and Blueprint Medicines 200-day simple moving average is 92.60, creating a Sell signal.

Fundamental Analysis of Blueprint Medicines

Is Blueprint Medicines a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.63 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.28 per share, and an increase next year of $2.63 per share.

Technical Analysis of Blueprint Medicines

Should I short Blueprint Medicines stock?

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.